Banner - NPPA Connect

News


All News

Advances in the diagnosis and treatment of vascular lesions are decreasing the morbidity and cosmetic disfigurement in some affected patients. Dermatologists should note that education and reassurance help parents understand the severity or non-severity of certain lesions and treatment protocols. Learn more

Expert offers patient-pass-along tips on prolonging the life of multi-bladed razors, reducing skin irritation, and reasons why body wash is not an alternative to shave cream.

A 52-year-old woman who spent much of her spare time gardening went to the doctor after noticing a mottled blanching patch on the sides and front of her neck and superior chest. She had noticed the rash months earlier, but it had slowly gotten worse and she wanted to know if there was a treatment.

Whether you’re writing a 100-character teaser on Twitter, a compelling blog, an attention-grabbing post or a short video script, content is what drives social media interaction, says social media expert Patricia Redsicker.

The FDA approved Taltz (ixekizumab, Eli Lilly and Company) injection 80 mg/mL March 22 for treatment of moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy. Learn more

Results of a relapse study indicate that patients with moderate-to-severe papulopustular rosacea experienced longer remission when treated with once-daily ivermectin 1% cream compared with initial treatment with twice daily metronidazole 0.75% cream.

The AAD’s new guidelines for the care and management of acne vulgaris include several updates for dermatologists, including an increased emphasis on oral antibiotic stewardship and recommendations for use.

The FDA is evaluating biosimilar medications for use in the United States. The approval of these medications in the next few years could mean big changes for dermatologists and their psoriasis patients

Promius Pharma's newly approved topical spray for psoriasis uses a sophisticated vehicle technology that allows a mid-potency steroid to act like a more potent steroid in actual clinical practice. Dr. Stein Gold explains how.

While low levels of vitamin D are linked with several diseases, ingesting too much vitamin D increases risks for other health conditions. In counseling patients on supplementation, one must take into consideration patient characteristics such as individual medical conditions and race.

A disruptive physician isn’t necessarily aggressive in an obviously obnoxious way. The disruption may come from behaving in a way that interferes with others’ work, not communicating across specialties or teams, or failing to give or receive effective feedback. Here’s what you can do to avoid a disrespectful and non-professional environment.

Patients are asking about dietary guidelines. One expert shares insight on how our food source is affecting skin health.

As opposed to trying to balance personal and professional commitments, dermatologists should align values and strengths and build their lives around these. One expert explains how one’s passion can translate to work.

Check out Dr. Wheeland's editorial as he shares what he believes the future of dermatology will become and how it will be practiced several decades from now.

Researchers are making important strides in better understanding the genetics of cutaneous T cell lymphoma (CTCL). This new knowledge could have major implications for improved diagnosis and, potentially, new targeted CTCL therapies.

A new study reveals that toxin-producing bacteria like staphylococcus may fuel CTCL; therefore, antibacterial treatment may slow disease progression. Findings could one day change how you treat patients.

There have been significant strides in the systemic treatment of metastatic melanoma, but these advances have not meant the elimination of surgery as part of the management of metastatic melanoma. Learn more